Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY: EW )

70.19 -0.19 (-0.27%)
Streaming Delayed Price Updated: 10:55 AM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Edwards Lifesciences

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
What 8 Analyst Ratings Have To Say About Edwards Lifesciences
Via Benzinga
A Preview Of Edwards Lifesciences's Earnings
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 30, 2023
Via Benzinga
Amazon To Rally Around 29%? Here Are 10 Other Analyst Forecasts For Monday
Barclays cut the price target for Amazon.com, Inc. (NASDAQ: AMZN) from $140 to $130. Barclays analyst Ross Sandler maintained an Overweight rating. Amazon shares fell 1.2% to $101.06 in pre-market... 
Via Benzinga
Expert Ratings for Edwards Lifesciences
Via Benzinga
15 Analysts Have This to Say About Edwards Lifesciences
Via Benzinga
Why Edwards Lifesciences Stock Crashed 16% Today
Did investors overreact to the company's miss? 
Via The Motley Fool
2 Smartest Tech Stocks to Buy in 2022 and Beyond
The tech space is still bursting with opportunities for long-term investors. 
Via The Motley Fool
Jim Cramer Recommends These 5 Healthcare Stocks For 2023: 'Biggest Winners Were Boring, Consistent Operators'
Prominent market commentator Jim Cramer has recommended five healthcare stocks which he believes should be on investors’ shopping list for 2023. 
Via Benzinga
JPMorgan To Rally Around 17%? Here Are 10 Other Price Target Changes For Tuesday
Via Benzinga
Reata Pharmaceuticals To Jump 220%? Plus JP Morgan Predicts $51 For Las Vegas Sands
Goldman Sachs boosted the price target on Reata Pharmaceuticals, Inc. (NASDAQ: RETA) from $86 to $115. Goldman Sachs analyst Madhu Kumar maintained the stock with a Buy rating. Reata Pharmaceuticals... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022
Via Benzinga
S&P 500 Component DexCom Set For Further Price, Earnings Growth
Glucose monitor maker DexCom surged 19% after its Q3 report, and shares are holding those gains. Wall Street sees more growth ahead in 2023. 
Via MarketBeat
Topics Stocks
Exposures US Equities
Benzinga's Top Ratings Upgrades, Downgrades For December 2, 2022
Via Benzinga
Edwards Life Sciences Stock Disaster Could Be Your Bounty
Heart disease equipment maker Edwards Life Sciences (NYSE: EW) stock has fallen (-46%) on the year after a disastrous reaction to its Q3 2022 earnings report. 
Via MarketBeat
Topics Death
Exposures COVID-19 Death
Cramer's Take On This Stock That's Down 53% Year-To-Date: 'I Think Long-Term. I Don't Want To Own It'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Cerence Inc. (NASDAQ: CRNC) can fall to $13, $12 in a market like this. "If you can take that level of pain, you can absolutely buy it, because it... 
Via Benzinga
7 Stocks to Buy at the ‘Midterm Elections’ Bottom
With the market tending to react positively to midterm election cycles, now may be a time to consider certain stocks to buy. 
Via InvestorPlace
Honeywell To $194? Plus Citigroup Slashes PT On This Stock By Over 93%
  Daiwa Capital slashed the price target on Honeywell International Inc. (NYSE: HON) from $206 to $194. Honeywell shares fell 0.6% to $203.79 in pre-market trading. 
Via Benzinga
Weibo, XPeng, Li Auto And Other Big Losers From Friday
U.S. stocks closed higher on Friday, with the Dow Jones gaining more than 800 points. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday
Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday. 
Via Benzinga
Nasdaq Climbs 275 Points; S&P 500 Rises Over 2%
U.S. stocks extended gains toward the end of trading, with the Nasdaq Composite surging more than 200 points on Friday. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers 
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,100 Today
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 5 years by 7.47% on an annualized basis producing an average annual return of 15.86%. Currently, Edwards Lifesciences has a... 
Via Benzinga
Economic Challenges Hit Edwards Lifesciences Q3 Earnings, Guidance Lags Wall Street Estimates
Via Benzinga
Dow Jumps 600 Points; Crude Oil Down Over 1%
U.S. stocks extended gains midway through trading, with the Dow Jones surging more than 600 points on Friday. 
Via Benzinga
US Stocks Mostly Higher; Dow Surges 300 Points
U.S. stocks traded mostly higher this morning, with the Dow Jones surging more than 300 points on Friday. 
Via Benzinga
Why Edwards Lifesciences Shares Are Trading Lower By Around 17%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) surged 179% to $3.6301. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2022
Upgrades 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Nuvalent (NASDAQ:NUVL) stock increased by 15.9% to $25.5 during Friday's pre-market session. The company's market cap stands at $1.2 billion. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Pre-market stock movers continue to be a major topic as we dive into the latest news investors need to know about on Friday! 
Via InvestorPlace
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.